FDA Approval: Tarlatamab 

Episode
223
Soundcloud
Share

In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recently approved bispecific T-cell engager, tarlatamab, for small cell lung cancer.

Guest
Stephen Liu
Stephen Liu

MD

Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Anne-Marie Dingemans
Anne-Marie Dingemans

MD, PhD

Pulmonologist in the Department of Pulmonary Diseases and Professor of Thoracic Oncology
Erasmus Medical Center
Ryan Gentzler
Ryan Gentzler

MD

Associate Professor and Director of the Thoracic Oncology Clinical Research Program
University of Virginia